Lonza Adds Cytokines and Viral Production Medium to Cell Therapy Portfolio
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
Read MorePosted by CLP Edit Staff | Oct 14, 2025 | Biochemicals & Chemical Reagents |
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
Read MorePosted by CLP Edit Staff | Oct 14, 2025 | Controls |
The quality control product now includes eight opioid drugs or drug metabolites at concentrations above and below assay cutoffs.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Molecular Diagnostic Analyzers |
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Cancer |
OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Prenatal Testing |
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
Read More